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Abstract
Background: Body mass index (BMI) independently predicts mortality in studies of HIV infected patients initiating
antiretroviral therapy (ART). We hypothesized that poorer nutritional status would be associated with smaller gains in CD4
count in Rwandan women initiating ART.
Methods and Findings: The Rwandan Women’s Interassociation Study and Assessment, enrolled 710 ART-naı ¨ve HIV-positive
and 226 HIV-negative women in 2005 with follow-up every 6 months. The outcome assessed in this study was change in
CD4 count at 6, 12, and 24 months after ART initiation. Nutritional status measures taken prior to ART initiation were BMI;
height adjusted fat free mass (FFMI); height adjusted fat mass (FMI), and sum of skinfold measurements. 475 women
initiated ART. Mean (within 6 months) pre-ART CD4 count was 216 cells/mL. Prior to ART initiation, the mean (6SD) BMI was
21.6 (63.78) kg/m
2 (18.3% malnourished with BMI,18.5); and among women for whom the following were measured,
mean FFMI was 17.10 (61.76) kg/m
2; FMI 4.7 (63.5) kg/m
2 and sum of skinfold measurements 4.9 (62.7) cm. FFMI was
significantly associated with a smaller change in CD4 count at 6 months in univariate analysis (26.7 cells/uL per kg/m
2,p
=0.03) only. In multivariate analysis after adjustment for covariates, no nutritional variable was associated with change in
CD4 count at any follow up visit.
Conclusion: In this cohort of African women initiating ART, no measure of malnutrition prior to ART was consistently
associated with change in CD4 count at 6, 12, and 24 months of follow up, suggesting that poorer pre-treatment nutritional
status does not prevent an excellent response to ART.
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Introduction
HIV-infection and poor nutritional status are prevalent in
Africa. In Rwanda, malnutrition defined by the World Health
Organization (WHO) definition of body mass index (BMI) ,
18.5 kg/m
2, [1] is substantially greater than in developed
countries [2]; in our preliminary studies of Rwandan HIV-positive
women in 2005 approximately 19% were malnourished [3].
Low body mass index (BMI) and serum albumin have been
shown to independently predict mortality in HIV infected persons
initiating ART in several United States and African studies
[4,5,6,7,8,9]; and also may be markers of advanced HIV disease
[5,10]. In an Ethiopian study, weight loss in the first month after
antiretroviral treatment (ART) initiation was associated with
shorter survival [6]. In the Tufts Nutrition for Healthy Living
Cohort as little as 5% weight loss over 6 months or 3% from
baseline, was associated with increased mortality in HIV infected
persons, even after adjustment for ART use [8]. Malnutrition can
lead to increased susceptibility to infection through suppression of
immune defense mechanisms, and HIV infection can cause
malnourishment through increased concomitant opportunistic
infections, malabsorption, and anorexia. However, dietary sup-
plementation with food, which could potentially increase weight
and improve nutritional status, has failed to consistently show
reductions in HIV mortality in both high- and low-resource
settings [11,12]. It is thus unclear whether nutritional measures
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and thus impending mortality, or are functioning independently as
causal factors for illness or death; these questions have important
programmatic and policy implications for food supplementation
for HIV infected persons.
If CD4 cell response to ART were lower in malnourished
compared to well-nourished individuals, this might imply a causal
role of malnutrition in HIV mortality. However, few studies have
investigated the association of malnutrition and CD4 response.
Those that did used only BMI or body weight as a marker of
malnutrition, which will not separately capture the different fat
and non-fat (i.e. protein) aspects of malnutrition.. In the Singapore
HIV Observational Cohort, there was no association of BMI
measured 2 months before or after ART initiation with the
magnitude of CD4 increase at 6 and 12 months after ART
initiation, although lower BMI was significantly associated with
reduced survival [13]. Among HIV infected patients initiating
ART in Cote d’Ivoire there was no difference in the proportion of
people who gained 50 or more CD4 cells/uL 6 months after ART
initiation among BMI categories .25, 18.5–25, and ,18.5 kg/m
2
[14].
BMI may provide an incomplete picture of pre-ART nutritional
status in HIV infected individuals. BMI is an easily measured and
well-validated indicator of malnutrition in populations without
HIV, but it may not capture the changes in body composition that
occur specifically in HIV infection because it does not distinguish
fat from protein. Starvation and cachexia are two pathologically
different forms of malnutrition that may occur in HIV-infected
populations; whereas starvation involves losses in body fat,
cachexia results in mainly a loss of lean body mass such as skeletal
muscle [14]. Further, in cachexia, changes in inflammation and
the acute phase response leads to an elevation in resting energy
expenditure and hypermetabolism, which in turn may affect
response to ART [15]. Therefore, height-normalized measures of
fat-free mass and fat mass may provide important information
about specific fat and protein malnutrition within these different
compartments in persons with HIV infection [16]. Skinfold
measurements may also capture malnutrition by providing an
estimate of subcutaneous fat. These measures have been validated
as nutritional markers in non-African populations with HIV [17].
In this cohort we previously showed correlation between these
measures (r
2=.48), and several small studies have shown high
correlation (r
2=.61 to .87) between fat mass and fat free mass
between calculated and anthropometric measures of body fat,
although among Africans of unknown HIV serostatus [18,19,20].
We therefore examined the association of nutritional status
prior to ART initiation, using height-normalized measures of body
mass, fat-free mass, fat mass, and skin fold thickness, with the
change in CD4 count at an average of 6, 12, and 24 months after
ART initiation in a cohort of Rwandan women with a high
prevalence of malnutrition at study entry.
Methods
Objectives
The objectives of this study were to examine the association of
nutritional status prior to ART initiation, using height-normalized
measures of body mass, fat-free mass, fat mass, and skin fold
thickness, with the change in CD4 count at an average of 6, 12,
and 24 months after ART initiation in a cohort of Rwandan
women with a high prevalence of malnutrition at study entry. We
hypothesized that poorer nutritional status would be associated
with smaller gains in CD4 count in Rwandan women initiating
ART.
Participants
The Rwanda Women’s Interassociation Study and Assessment
(RWISA) is an observational prospective cohort of 710 ART-naı ¨ve
(at enrollment) HIV-infected and 226 HIV-uninfected Rwandan
women enrolled in 2005 [21]. Briefly, participants met the
following inclusion criteria: age 25 years or older at study entry,
willingness to give informed consent, presence in Rwanda during
1994. Participants were excluded if there was a prior history of
receiving antiretroviral treatment other than single-dose nevir-
apine to prevent mother-to-child transmission of HIV. At study
entry and at six-month interval visits, participants provided
historical information including socio-demographics, medical
history and symptoms, anthropometric measurements and blood
specimens.
At each follow up visit, participants were asked whether they
had initiated ART. Women reporting ART initiation provided
written documentation of the exact date of ART initiation and
medication regimen. From 2005 through 2007, following WHO
and Rwandan guidelines, women in this cohort were eligible for
ART if they had: WHO Stage IV disease, irrespective of CD4 cell
count; WHO Stage III disease with CD4 ,350 cells/mL; or CD4
,200/mL regardless of clinical stage. In 2008 Rwandan guidelines
expanded the CD4 criterion to include ART initiation in all
patients with CD4,350 cells/ml.
Included in this analysis are all HIV-positive RWISA
participants who initiated ART after study entry, had a CD4
count obtained within one year prior to ART initiation (pre-ART
CD4 count), nutritional measures at the pre-ART CD4 visit, and
at least 6 months of follow-up with a CD4 measurement.
Body composition and anthropometric measurements
Height and weight were measured while the participant was
wearing light clothing and no shoes. Body impedance analysis
(BIA) was performed twice using a standard tetrapolar electrode
placement on the hand and foot with resistance and reactance
recorded. Skin-fold measurements were obtained by study nurses
who were trained on techniques for standardized anthropometric
measurement, using correct anatomic location of skin folds.
Laboratory Methods
CD4 counts were determined with a FACS counter (Becton and
Dickinson, Immunocytometry Systems, San Jose, CA, USA).
Outcome variables
The main outcome of interest was change in CD4 count from
the pre-ART to the 6, 12, and 24 month follow-up visits. Pre-ART
values were defined as those measured at the study visit which fell
between 1 day and 12 months prior to the exact date of ART
initiation. If there were multiple visits in this time window, we
chose the date closest to the exact date of ART initiation. The 6-,
12- and 24-month follow up visits were defined as the study visits
which fell between 3 and 9 months, 9 and 15 months, and 21 and
27 months respectively after the exact date of ART initiation.
Because some participants did not complete their follow-up at
exact 6 month intervals, it was possible to have more than one visit
in the follow up range, in which case the visit closest to the 6, 12,
or 24 month follow up date was used.
The change in CD4 was calculated as the absolute CD4 count
at the follow up visit minus the pre-ART CD4 count. Since the
pre-ART CD4 count visit was on average 91 days (3 months) prior
to the exact date of ART initiation, the change in CD4 at 6
months reflects on average a change over 9 months (with on
average 6 of these months on ART). The change in CD4 at 12
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average 12 months on ART), and the change in CD4 at 24
months reflects on average a change over 27 months (with on
average 24 months on ART).
Nutritional predictor variables
Four nutritional indicators were used, all from the pre-ART
visit: body mass index (BMI); fat free mass index (FFMI); fat mass
index (FMI); and the sum of skinfold measurement at the mid
triceps, front thigh, and sub-scapular regions.
BMI, obtained from standing height and weight measurements,
was calculated as weight divided by height-squared (kg/m
2). We
used WHO-established BMI cutoffs for nutritional status:
malnourished (BMI , 18.5 kg/m
2), normal (BMI 18.5–25 kg/
m
2), and overweight (BMI$25 kg/m
2) [1].
FFMI was obtained from BIA as described above. Resistance
and reactance were entered into standard formulae to calculate fat
free mass in kg; these formulae have been previously validated in a
multi-ethnic HIV and non-HIV population in the United States,
and have been used in several African-studies [17,22,23,24,25].
For ,5% of the participants the calculated FFM exceeded weight
and was thus set to equal the weight. We then standardized the
calculated fat free mass by dividing it by height in meters, squared,
to obtain the FFMI (kg/m
2). The FMI was calculated as weight in
kg minus fat free mass in kg, and was standardized for height by
dividing by height-squared (kg/m
2).
Skinfolds measurements were taken twice by the same person at
each site of mid triceps, front thigh, and sub-scapular region, and
the average of the two measurements was used for analysis. If the
two measurements differed by $2.0 mm, a third measure was
taken and the closest two were averaged. The sum of the skinfolds
measurement was the sum of the triceps, thigh and sub-scapular
measurements in centimeters.
Covariates
We included the following covariates obtained at the pre-ART
visit because of their potential to confound the relationship
between malnutrition and change in CD4 count: age, income,
education, CD4 count, and self-reported prior occurrence of a
Stage 4 WHO AIDS defining illness (ADI). Smoking was not
included in the analysis as less than 3% of the women smoked.
Age was included as age per 5 years. Income was categorized as
,10,000 Rwandan francs (FRW) per month (in 2005, this was
equivalent to , $17), 10,000 to 35,000 FRW per month, and
greater than 35,000 FRW per month. Education was categorized
as none, some primary school, completed primary school, or some
secondary school or higher. Pre-ART CD4 count was included in
the analysis per 100 cells/mL increment. We determined the
presence of Stage 4 WHO illness from participant self-report at all
visits prior to and including the pre-ART study visit.
Ethics
Each participant provided written informed consent after
viewing a video demonstrating study procedures, and discussing
the study with research personnel. Study protocols were approved
by the Rwanda National Ethics Committee and the Institutional
Review Board of Montefiore Medical Center.
Statistical Methods
The primary outcomes were changes in CD4 count (as a
continuous variable), from the pre ART visit at 6, 12, and 24
months of follow up, as defined above. Univariate linear regression
analysis was performed for the change in CD4 count at the 6-, 12-,
and 24-months post ART. All nutritional measures were analyzed
as continuous variables. Other covariates were analyzed as
described above.
For the multivariate analysis, we created four multivariate linear
regression models each containing one of the nutritional variables
alone in the model (BMI, FFMI, FMI or skinfold sum) with the
covariates listed above. This was performed 3 times using change
from pre-ART visit to 6, 12, and 24 months post-ART as the
outcome. We used backwards selection analysis with a p-value of
p=0.1 to stay. Variables that did not reach statistical significance
were removed from the model until we obtained a final model.
SAS software, version 9.1.3 (Cary, North Carolina) was used for
the analysis.
Results
Table 1 displays demographic and clinical characteristics of the
537 included women. The median preART CD4 count was 200
(interquartile range 142 to 279) cells/mL, The mean time from
pre-ART measurement to the 6 month follow up visit was 244
days (8.0 months) with a median of 210 days (6.9 months); to the
12 month follow up visit, 425 days (14.0 months) with a median of
390 days (12.8 months); and to the 24 month follow up visit, 777
days (25.6 months) median of 771 days (25.3 months).
Prior to ART initiation, the mean (6Standard Deviation) BMI
was 21.6 (63.8) kg/m
2, with 18.3% of the women classified as
Table 1. Characteristics of 537 HIV-infected women
participants prior to initiation of antiretroviral therapy.
Variable Mean±SD or N(%)
Demographic variables
Age, years (n=537) 35.266.9
Income, RWF/year (n = 525)
Income ,10,000 192 (36.6%)
Income 10,000–35,000 266 (50.7%)
Income .35,000 67 (12.8%)
Education (n= 531)
None 118 (22.2%)
Some primary school 200 (37.7%)
Completed primary school 156 (29.4%)
Some secondary or higher 57 (10.7%)
CD4 count, cells/mL (n=537) 2166114
CD4 , 200 269 (50.1%)
CD4 200–350 212 (39.5%)
CD4 .350 56 (10.4%)
WHO Stage 4 illness prior to ART (n = 224) 224 (41.7%)
Nutritional variables
BMI, kg/m
2 (n=526) 21.663.8
BMI , 18.5 96 (18.3%)
BMI 18.5–20 95 (18.1%)
BMI .20 335 (63.7%)
FFMI, kg/m
2 (n=463) 17.161.8
FMI, kg/m
2 (n=463) 4.763.5
Skinfold sum, cm (n=489) 4.962.7
Abbreviations: RWF=Rwandan Francs; WHO= World Health Organization;
BMI=body mass index; FFMI=fat free mass index; FMI=fat mass index.
doi:10.1371/journal.pone.0029625.t001
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were 17.1 (61.8) kg/m
2 and 4.7 (63.5) kg/m
2 respectively. The
sum of these means (17.1 kg/m
2 + 4.7 kg/m
2) does not equal the
mean BMI (21.6 kg/m
2), as some people with BMI were missing
BIA measures and thus did not have a calculated FMI and FFMI.
The mean pre-ART sum of the three skinfolds measurements was
4.9 (602.7) cm.
The mean changes in CD4 count from pre ART initiation at 6, 12,
and 24 months post initiation were 71 (6107), 89 (6109) and 153
(6135) cells/mL, respectively. In univariate linear models (Table 2), the
only significant association (at p , 0.05) between any nutritional
measure and pre-post ART change in CD4 count occurred at 6
months of follow up. A higher FFMI was associated with a smaller
increase in CD4 count at 6 months (27 cells/mLp e rk g / m
2, p =0.03).
For example, those with a FFMI of 17 kg/m
2 gained on average 7
fewer CD4 cells/mL from the pre-ART visit to the 6 month post-ART
visit compared to those with a FFMI of 16 kg/m
2.B M I ,F M Ia n d
skinfold measurements were not associated with change in CD4 count
at 6 months. The changes in CD4 count at 12 and 24 months were not
significantly associated with any of the pre-ART nutritional measure-
ments in univariate analysis.
A higher pre-ART CD4 count was strongly and significantly
associated in univariate analysis with smaller CD4 increases at all
timepoints (p,0.0001 for all) perhaps in part reflecting regression
to the mean [26]. Of the demographic variables, at 6 months of
follow up the only statistical association was with educational
attainment: those having secondary school or higher compared to
no education had a smaller increase in CD4 count (p=0.001). At
12 and 24 months of follow up, an income of 10,000 to 35,000
FRW was associated with a smaller increase in CD4 count
(p=0.03 and p=0.02, respectively).
In the four backwards selection models (BMI, FFMI, FMI, and
sum of the skinfolds), no nutritional variable met criteria to stay in
the adjusted models and thus none was independently associated
with a change in CD4 cell count from pre-ART to 6, 12, or 24
months post-ART after adjustment for covariates (data not
shown). In particular FFMI, which was associated with change
in CD4 count at 6 months in univariate analysis, was no longer
independently associated with this outcome in multivariate
analysis. In all multivariate models preART CD4 remained
independently inversely associated with change in CD4 at all time
points (range from 213 and 236 cells/ml per 100 cells/ml
increment; p=.01 to p,0.0001).
Discussion
We did not find any association between BMI, FFMI, FMI or
skinfolds measurements and the change in CD4 count from the
pre-ART visit to 6, 12, or 24 months after ART initiation. In our
study, we examined not only BMI, but a panel of anthropometric
measures through the use of FFMI, FMI, and skinfolds to better
capture pre-ART nutritional status in terms of loss of fat or protein
within these body compartments. We found that none of these
measures predicted change in CD4 count at any time point after
initiation of ART, especially after adjustment for other known
predictors of CD4 response such as pre-ART CD4 count, HIV
viral load, or history of WHO Stage 4 AIDS defining illness. Thus,
having a low BMI, low fat mass, low fat free (protein) mass or thin
skinfolds did not preclude a robust response to ART as measured
by the change in CD4 count. These multiple measures of either fat
or protein loss, such as experienced in starvation or cachexia, were
not associated with the ability to gain CD4 cells at several post-
Table 2. Univariate variables and Change in CD4 count at 6, 12, and 24 months from pre-ART visit.
Variable Change in CD4 count, cells/mL from pre-ART visit
6 month change 12 month change 24 month change
n estimate p n estimate p n estimate p
Nutritional variables
BMI, per kg/m
2 466 0.24 0.86 391 21.5 0.35 294 20.10 0.96
FFMI, per kg/m
2 406 26.7 0.03 330 2.44 0.89 253 26.9 0.15
FMI, per kg/m
2 406 1.8 0.28 330 21.2 0.51 253 2.2 0.46
Skinfold sum, per cm 432 20.40 0.83 353 22.0 0.29 271 23.3 0.19
Demographic variables
Age (per 5 years) 475 21.4 0.69 397 23.1 0.43 296 21.5 0.80
Income, RWF/year 475 397 296
,10,000 baseline Baseline Baseline Baseline
10,000–35,000 210 0.34 226 0.03 241 0.02
.35,000 225 0.12 226 0.13 216 0.51
Education 475 397 296
No education baseline Baseline Baseline Baseline
Some primary 214 0.30 27 0.61 26.2 0.77
Completed primary 213 0.36 219 0.22 29.5 0.66
Some secondary or higher 259 0.001 231 0.13 215 0.61
Pre-ART CD4 count, per 100 cells/ul 475 221 ,0.0001 397 213 ,0.0001 296 227 ,0.0001
WHO Stage IV illness prior to ART 475 21.5 0.88 397 22 0.05 296 29.6 0.55
Abbreviations: ART=antiretroviral therapy, BMI=body mass index, FFMI=fat free mass index, FMI=fat mass index, RWF= Rwandan Francs, WHO=World Health
Organization.
doi:10.1371/journal.pone.0029625.t002
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association we observed in univariate analysis (FFMI with CD4
change at 6 months) was in the opposite direction, suggesting a less
robust response with higher FFMI. These anthropometric findings
are similar to the findings from by Paton, Koethe and Toure, who
examined only pre-treatment BMI and various responses to CD4
count and found no associations. To our knowledge, this is the first
study to examine several anthropometric pre-ART markers of
nutritional status and their associations with changes in CD4
count, particularly in African subjects.
It is possible that our measures may not have accurately
captured nutritional status prior to treatment. However, our recent
study of this cohort has shown that serum albumin levels,
traditionally thought of as a marker of nutritional status, also did
not correlate well with FMI, FFMI, BMI, or skinfolds [27]. Serum
albumin was lowest in the lowest CD4 count strata, and thus was
more likely a marker of disease severity than of nutritional status.
Limitations
Some limitations to this study should be noted. Although the
exact dates of ART initiation were known, the time from the pre-
ART nutritional measurements to follow up visit varied. However,
our results show that the time from the pre-ART measurements to
follow up visits was generally within 1–2 months of the goal follow
up at 6, 12, and 24 months. Another limitation is that the
resistance and reactance measurements, obtained from BIA
measurements, were used to calculate fat mass and fat free mass
in equations derived from a white and African-American
population which may not completely reflect the relationships in
Rwanda [17], although these equations have been used in several
published studies in Africa [22,23,24,25]. We also note inter-
operator variability when obtaining skinfold measurements,
although we took care with multiple measurements for accuracy
by our trained nurses. We were unable to define fully from
participant self-report all WHO Stage 4 AIDs defining illnesses
prior to initation of ART, as some of these illnesses were not
specifically inquired about; thus we may not have accurately
captured all confounding illness. Finally, caution must be made in
extrapolating these data to populations with different levels of
malnutrition.
Conclusions
In summary, we found that pre-ART nutritional status, as
measured by BMI, FFMI, FMI and skinfolds did not predict the
pre to post ART initiations changes in CD4 count at 6, 12, and 24
months after ART initiation in a cohort of HIV infected Rwandan
women. Thus having poor values on these anthropometric
measures may not preclude an excellent response to ART as
measured by CD4 count. Further studies are warranted, using
additional measures of nutritional status and with longer follow-up
time, to assess further the impact of malnutrition on surrogate
markers and clinical outcomes including mortality in Africans
initiating ART.
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